[Exhibition Recap] Hunan Xianshi Pharmaceutical Concludes Successful Participation at CPHI China 2025

Release date:

2025-06-30


SHANGHAI, June 30, 2025 — CPHI China 2025, the three-day World Pharmaceutical Ingredients Exhibition, wrapped up at Shanghai New International Expo Center from June 24 to 26. As a reliable supplier specializing in APIs, pharmaceutical intermediates and excipients, Hunan Xianshi Pharmaceutical Co., Ltd. presented its core products and newly developed innovations at Booth E12D76, Hall E1. The company attracted wide attention and conducted in-depth communications with global clients and industrial counterparts.

A Remarkable Debut to Demonstrate Core Competencies

The on-site reception team, led by the API Business Unit and consisting of specialists from R&D, production and regulatory departments, delivered full-spectrum consulting services during the show and won favorable feedback from visiting clients.

Cooperation Extends Beyond the Exhibition Floor

While the exhibition has ended, partnership development will continue. Adhering to the corporate tenets of quality-oriented production, compliance-based operation and customer-centric service, Xianshi Pharmaceutical will further expand cross-border cooperation and global market layout for its APIs, intermediates and excipient products.

Parties who missed on-site communication are welcome to reach out for product information and relevant documents via email: caoxin@hnxspharma.com

The company sincerely appreciates all new and existing customers, partners and industry peers for visiting its booth. Valuable feedback and support fuel the company’s continuous growth. Going forward, following the corporate philosophy of prioritizing client value for mutual progress, Xianshi Pharmaceutical aims to contribute to global healthcare development with Chinese pharmaceutical expertise.

We look forward to meeting you again at next year’s CPHI China.